How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan? |
| July 30, 2019 | July 2019 Bond Updates |
|
Pfizer (NYSE:PFE) today announced its plan to combine its generic drugs business with Mylan in a Reverse Morris Trust transaction. The combined entity could generate sales of over $20 billion by 2020, and Pfizer will hold a 57% stake in the new company, with Mylan holding the rest. In this note ... |
| View more at: https://www.forbes.com/sites/greatspeculations/2019/07/29/how-big-is-pfizers-generic-drugs-business-that-it-plans-to-merge-with-mylan/ |
| Related News |